Literature DB >> 25680591

The case for prostate brachytherapy in the Affordable Care Act era.

Ben Y Durkee1, Mark K Buyyounouski2.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25680591     DOI: 10.1016/j.ijrobp.2014.10.014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  1 in total

1.  Utilization of prostate brachytherapy for low risk prostate cancer: Is the decline overstated?

Authors:  Joseph Safdieh; Andrew Wong; Joseph P Weiner; David Schwartz; David Schreiber
Journal:  J Contemp Brachytherapy       Date:  2016-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.